In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR. [electronic resource]
Producer: 20060705Description: 709-18 p. digitalISSN:- 0344-5704
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cell Line, Tumor
- Cetuximab
- Colorectal Neoplasms -- drug therapy
- Drug Synergism
- ErbB Receptors -- metabolism
- Female
- Humans
- Mice
- Mice, Nude
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Phosphorylation
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.